Correlation Between ZyVersa Therapeutics and Coeptis Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Coeptis Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Coeptis Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Coeptis Therapeutics, you can compare the effects of market volatilities on ZyVersa Therapeutics and Coeptis Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Coeptis Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Coeptis Therapeutics.

Diversification Opportunities for ZyVersa Therapeutics and Coeptis Therapeutics

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between ZyVersa and Coeptis is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Coeptis Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coeptis Therapeutics and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Coeptis Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coeptis Therapeutics has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Coeptis Therapeutics go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and Coeptis Therapeutics

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Coeptis Therapeutics. In addition to that, ZyVersa Therapeutics is 3.21 times more volatile than Coeptis Therapeutics. It trades about -0.15 of its total potential returns per unit of risk. Coeptis Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest  21.00  in Coeptis Therapeutics on August 31, 2024 and sell it today you would lose (1.00) from holding Coeptis Therapeutics or give up 4.76% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

ZyVersa Therapeutics  vs.  Coeptis Therapeutics

 Performance 
       Timeline  
ZyVersa Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Coeptis Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Coeptis Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable technical and fundamental indicators, Coeptis Therapeutics is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

ZyVersa Therapeutics and Coeptis Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ZyVersa Therapeutics and Coeptis Therapeutics

The main advantage of trading using opposite ZyVersa Therapeutics and Coeptis Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Coeptis Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeptis Therapeutics will offset losses from the drop in Coeptis Therapeutics' long position.
The idea behind ZyVersa Therapeutics and Coeptis Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency